<style face="normal" font="default" size="100%">High-Throughput Sequencing of microRNAs in Glucocorticoid Sensitive Paediatric Inflammatory Bowel Disease Patients.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">High-Throughput Sequencing of microRNAs in Glucocorticoid Sensitive Paediatric Inflammatory Bowel Disease Patients.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Action of methotrexate and tofacitinib on directly stimulated and bystander-activated lymphocytes.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Differential expression of GAS5 in rapamycin-induced reversion of glucocorticoid resistance.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Thiopurine Biotransformation and Pharmacological Effects: Contribution of Oxidative Stress.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Effect of Thalidomide on Clinical Remission in Children and Adolescents with Ulcerative Colitis Refractory to Other Immunosuppressives: Pilot Randomized Clinical Trial.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with Crohn's disease.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Genetic determinants for methotrexate response in juvenile idiopathic arthritis.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Role of oxidative stress mediated by glutathione-s-transferase in thiopurines' toxic effects.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Fate of lymphocytes after withdrawal of tofacitinib treatment.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Pharmacogenetics of azathioprine in inflammatory bowel disease: a role for glutathione-S-transferase?</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Association between BclI polymorphism in the NR3C1 gene and in vitro individual variations in lymphocyte responses to methylprednisolone.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Personalized therapies in pediatric inflammatory and autoimmune diseases.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Differential action of 3-hydroxyanthranilic acid on viability and activation of stimulated lymphocytes.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Genetic predictors of glucocorticoid response in pediatric patients with inflammatory bowel diseases.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease.</style>